Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation

被引:0
作者
Paul B. Massion
Pierre Peters
Didier Ledoux
Valentine Zimermann
Jean-Luc Canivet
Pierre P. Massion
Pierre Damas
André Gothot
机构
[1] University Hospital Centre of Liege,Medicosurgical Intensive Care Unit
[2] University Hospital Centre of Liege,Laboratory Hematology and GIGA
[3] Vanderbilt University Medical Center,Research
来源
Intensive Care Medicine | 2012年 / 38卷
关键词
Septic shock; Blood coagulation disorders; Thrombin; Anticoagulants; Thromboelastography; Disseminated intravascular coagulation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1326 / 1335
页数:9
相关论文
共 329 条
[1]  
Amaral A(2004)Coagulation in sepsis Intensive Care Med 30 1032-1040
[2]  
Opal SM(2007)A comparative study of the protein C pathway in septic and nonseptic patients with organ failure Am J Respir Crit Care Med 176 878-885
[3]  
Vincent JL(2006)What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26 41-48
[4]  
Borgel D(1998)Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock Crit Care Med 26 2005-2009
[5]  
Bornstain C(2000)The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation Blood 96 554-559
[6]  
Reitsma PH(2007)Fibrin and fibrinolysis in infection and host defense J Thromb Haemost 5 24-31
[7]  
Lerolle N(2002)Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock Clin Appl Thromb Hemost 8 225-230
[8]  
Gandrille S(2003)Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial JAMA 290 238-247
[9]  
Dali-Ali F(2011)Recombinant tissue factor pathway inhibitor in severe community-acquired pneumonia: a randomized trial Am J Respir Crit Care Med 183 1561-1568
[10]  
Esmon CT(2001)Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial JAMA 286 1869-1878